This is a randomized, double-blind, placebo-controlled study that will investigate the safety and clinical activity of a single intravenous (IV) dose of MHAA4549A in adult participants hospitalized with severe influenza A in combination with oseltamivir versus a comparator arm of placebo with oseltamivir.
Inclusion Criteria:
Exclusion Criteria:
Mont-godinne, 5530, Belgium
Sofia, 1606, Bulgaria
Veliko Tarnovo, 5000, Bulgaria
Victora, British Columbia V8Z 6R5, Canada
Brescia, Basilicate, Italy
Salerno, Sardinia 84131, Italy
La Victoria, Lima 13, Peru
Lodz, 91-347, Poland
Torun, 87-100, Poland
Parktown West, 2196, South Africa
Barcelona, Cantabria 08036, Spain
Mataro, Cantabria 08304, Spain
Mamö, 205 02, Sweden
London, WC1E 6AU, United Kingdom
Stoke-on-Trent, ST4 6QG, United Kingdom